Otezla 30mg (apremilast) is a brand-name prescription medication. It comes as a tablet you take by mouth. Otezla 30mg is used to treat plaque psoriasis and psoriatic arthritis, a form of arthritis that can occur in people with psoriasis.
Otezla 30mg belongs to a class of medications called disease-modifying antirheumatic drugs (DMARDs). Drugs in this class can slow down or stop certain conditions that are caused by an overactive immune system.
Otezla side effects
Otezla 30mg can cause mild or serious side effects. The following list contains some of the key side effects that may occur while taking Otezla. This list doesn’t include all possible side effects.
For more information on the possible side effects of Otezla, or for tips on how to deal with a troubling side effect, talk with your doctor.
More common side effects
The more common side effects of Otezla include:
Most of these effects may go away within a few days or a couple of weeks. If they’re more severe or don’t go away, talk to your doctor.
Serious side effects
Serious side effects and their symptoms can include the following:
severe diarrhea, nausea, or vomiting
Otezla 30mg can interact with several medications. It can also interact with certain supplements.
Otezla and other medications
Below is a list of medications that can interact with Otezla. This list doesn’t contain all drugs that may interact with Otezla.
Different drug interactions can cause different effects. For instance, some can interfere with how well a drug works, while others can cause increased side effects.
Before taking Otezla 30mg, be sure to tell your doctor and pharmacist about all prescription, over-the-counter, and other drugs you take. Also tell them about any vitamins, herbs, and supplements you use. Sharing this information can help you avoid potential interactions.
Forms and administration
Otezla is available as a tablet that’s taken by mouth twice daily. Stelara is a self-administered injection that’s taken once every 12 weeks.
Both Otezla and Stelara are effective for treating psoriasis and psoriatic arthritis. These drugs haven’t been directly compared in clinical studies.
In separate clinical studies in people with psoriasis, about 20 percent of people taking Otezla had their skin become completely clear or almost completely clear. In people receiving Stelara, about 60–75 percent had those effects.
In other studies, Otezla improved symptoms of psoriatic arthritis by 20 percent in about 30–40 percent of people who took it. In people receiving Stelara, about 40–50 percent of people had a 20 percent improvement in symptoms.
When comparing drugs, keep in mind that your doctor will make treatment choices based on your individual needs. They’ll consider several factors, such as your age, gender, childbearing potential, other conditions you may have, your risk of side effects, and how severe your condition is.